SELLAS Life Sciences Group, Inc. Disposal Group, Including Discontinued Operation, Liabilities, Current
SELLAS Life Sciences Group, Inc. (SLS) had Disposal Group, Including Discontinued Operation, Liabilities, Current of $6.76 million as of 2017-09-30, per its 10-Q filed 2017-11-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent · last filed 2017-11-09
- 2017-09-30: Disposal Group, Including Discontinued Operation, Liabilities, Current $6.76M.
- 2017-06-30: Disposal Group, Including Discontinued Operation, Liabilities, Current $8.69M.
- 2017-03-31: Disposal Group, Including Discontinued Operation, Liabilities, Current $10.04M.
- 2016-12-31: Disposal Group, Including Discontinued Operation, Liabilities, Current $6.06M.
| Period end | Disposal Group, Including Discontinued Operation, Liabilities, Current |
|---|---|
| 2017-09-30 | $6.76M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $8.69M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $10.04M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $6.06M 10-Q · filed 2017-11-09 |
| 2016-09-30 | $4.20M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $3.73M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $4.49M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $5.92M 10-K · filed 2017-03-15 |
| 2015-09-30 | $7.70M 10-Q · filed 2015-11-09 |
| 2014-12-31 | $7.17M 10-K/A · filed 2016-04-15 |
| 2013-12-31 | $4.61M 8-K · filed 2015-12-04 |
| 2012-04-27 | $1.61M 10-K · filed 2013-03-12 |
| 2011-12-31 | $1.75M 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |